Zepp Health Corporation (ZEPP) Misses Q2 EPS by 19c; offers outlook

Zepp Health Corporation (NYSE: ZEPP) reported Q2 EPS of (RMB0.15), RMB0.19 worse than the analyst estimate of RMB0.04. Revenue for the quarter came in at RMB40.64 million, versus RMB0 reported last year.

GUIDANCE:

Zepp Health Corporation sees Q3 2024 revenue of RMB45-60 million, versus the consensus of RMB102.7 million.

For earnings history and earnings-related data on Zepp Health Corporation (ZEPP) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• JPMorgan Upgrades FOX Corp. (FOXA) to Overweight